Expect Trikafta for Cystic Fibrosis to Be Continued In-House
February 2020
Trikafta (try-KAF-tuh, elexacaftor/tezacaftor/ivacaftor) will be a game changer for treating cystic fibrosis.
This genetic disorder causes thick mucus to build up in the lungs and other parts of the body...leading to serious breathing problems and other complications.
The go-to meds for treating the gene mutations that cause cystic fibrosis have been Kalydeco, Orkambi, or Symdeko.
Practical advice for a better career, with unlimited access to CE
Hospital Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote